Uncategorized
-
A review on tyrosine kinase inhibitors for targeted breast cancer therapy
Vidya Sankarapandian, Ramya Lakshmi Rajendran, Conrad Ondieki Miruka, Poornima Sivamani, Balu Alagar Venmathi Maran, Rajapandiyan Krishnamoorthy, Prakash Gangadaran, Byeong-Cheol Ahn Pathology-Research and Practice (2024), 263: 155607. DOI: https://doi.org/10.1016/j.prp.2024.155607 Abstract Breast cancer is a heterogeneous disease with complex molecular pathogenesis. Overexpression of several tyrosine kinase receptors is associated with poor prognosis, therefore, they can be key…
-
Article published by Vidya Sankarapandian et al in 2024-[EN]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[HI]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[TR]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[DE]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[FIL]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[JA]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[HR]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[TA]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024
-
Article published by Vidya Sankarapandian et al in 2024-[PL]
The article whose PDF is attached below was published by Vidya Sankarapandian et al in 2024